IAPP and type 2 diabetes mellitus: As for type II diabetes, although the molecular mechanism of its pathogenesis remains elusive, there is also evident that the key pathological species are transient β-sheet-rich oligomers of IAPP, which therefore represent therapeutic targets for treatment of type II diabetes [26], [28]–[30].